Cardiac Dimensions
Australia - SydneyBiotechnology
Focus: Cardiac Dimensions is an Australian-based medical device biotech specializing in minimally invasive heart valve correction systems, specifically the Carillon Mitral Contour System for mitral regurgitation treatment.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Cardiac Dimensions
AI assessmentNot HiringNo open roles listed right now. Follow Cardiac Dimensions to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Carillon Mitral Contour System
Stable
Pre-Commercial
Lead asset in development with multiple trial designations across mitral regurgitation indications, positioning for potential regulatory pathway.
Pipeline & Clinical Trials
Help build intelligence for Cardiac Dimensions
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.